$CL

CAHILL JOHN T sold $389K of CL

CAHILL JOHN T sold 4,170 shares of COLGATE PALMOLIVE CO (CL) at $93.37 ($0.39M total) on 2026-08-06.

Original reporting
SEC EDGAR · CAHILL JOHN T
Published Aug 7, 2026, 9:23 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 9:29 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CL
Neutral
medium confidence
Mentioned
$CL
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CLNeutralLow
01

Why it matters

The newest disclosed fact is the open-market sale of 4,170 shares at $93.3712 on 2026-08-06, with holdings after the sale of 28,373 shares.

02

Market read

Traders may note insider selling as a minor sentiment input, but there is no accompanying company-specific fundamental catalyst in the text.

03

What to watch

Insider sales can be driven by diversification, liquidity needs, or scheduled personal events; without context on prior holdings or compensation, signal strength is weak.

Relevance 4/10Novelty 3/10Timing: filed after-hours on 2026-08-07, covering a sale dated 2026-08-06

Background

The article is an SEC Form 4 insider transaction disclosure for Colgate Palmolive (CL) by director John T. Cahill.

Company-level read

Ticker impact

$CLNeutralMedium confidence
Context

Colgate Palmolive director John T. Cahill sold 4,170 shares in an open-market transaction worth about $389,358 on 2026-08-06.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven rather than fundamental.

Evidence & confidence

The filing is a Form 4 insider transaction, but the article provides no accompanying company news, guidance, or operational/regulatory catalyst.

Market effects

No clear sector read-through from a single director sale.

None indicated.

None indicated.

Counterpoint

The sale may be pre-planned or tax-related even if the filing states no 10b5-1 plan, so it may not reflect bearish fundamentals.

Key entities

  • COLGATE PALMOLIVE CO

    Subject of the Form 4 insider sale disclosure.

  • CAHILL JOHN T

    Director who sold shares via open-market sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PGMed

Weather Dividend Stocks That Keep Writing Bigger Checks

Procter & Gamble (PG) raised its dividend for 70 consecutive years, with fiscal 2026 free cash flow of $15.835B. Coca-Cola (KO) reported 5% unit case volume growth, its strongest in 17 years. Colgate-Palmolive (CL) saw 16.12% YTD stock growth and raised its dividend. All three companies demonstrated recession-resilient cash flows and dividend increases.

$PGMedAI 8/10

2 Dividend Kings, 1 Clear Winner: P&G vs. Colgate

Procter & Gamble (PG) and Colgate-Palmolive (CL) recently paid dividends. PG offers a higher yield (2.93%) and better coverage, while CL has stronger recent price performance. PG plans to return $15B to shareholders in fiscal 2027, including $10B in dividends. CL trades at a higher P/E (35x) with a smaller yield (2.33%).

$CLHigh

Colgate-Palmolive India Share Price Target at Rs 2,500: Motilal Oswal

Motilal Oswal reaffirmed a BUY rating for Colgate-Palmolive India, setting a price target of Rs 2,500, a 27% upside from the current price of Rs 1,965. The brokerage values the company at 40 times its estimated March 2027 earnings, citing strong growth pillars, premiumisation, and high margins. Colgate's strategy focuses on consumption creation and scientific premiumisation, with a 52-week range of Rs 1,782–2,505.